Potential interactions between antineoplastic agents and medicines used to treat Covid-19.
Mario Jorge Sobreira da SilvaClaudia Garcia Serpa Osorio-de-CastroRafael Duarte PaesChristopher Lucas NegreteElizangela EugênioElaine Lazzaroni MoraesAnnemeri LivinalliPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Covid-19 is a recent disease and pharmacological interventions are undergoing constant modification. This study identified a considerable number of potential drug-drug interactions. In view of the vulnerability of patients with cancer, it is vital that health professionals carefully assess the risks and benefits of drug combinations.